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Objectives. The present study was performed to determine the
outcome of emergent balloon mitral valvotomy (BMV) in patients
with cardiac arrest, pulmonary edema or cardiogenic shock.
Background. In India, many patients with mitral stenosis
present in critical condition. They have high mortality despite
surgical relief. The role of BMV in such patients is ill-defined.
Methods. Of 558 patients undergoing BMV between January
1993 and December 1994, 40 presented with cardiogenic shock,
cardiac arrest or pulmonary edema refractory to medical treat-
ment and underwent emergent BMV (group I). Elective BMV was
performed in the remaining 518 patients (group II).
Results. Age ([mean 6 SD] 40 6 13 vs. 31 6 9 years, p < 0.05),
incidence of atrial fibrillation (35% vs. 11%, p < 0.05), pulmonary
artery systolic pressure (PAsP) (64 6 14 vs. 51 6 12 mm Hg, p <
0.001) and mitral valve (MV) score (7.4 6 1.2 vs. 6.4 6 1, p <
0.001) were higher and MV area lower (0.74 6 0.17 vs. 0.86 6 0.14
cm2, p < 0.001) in group I patients. After emergent BMV in group
I, mitral regurgitation occurred in 15%, and the mortality rate was
35%. Stepwise logistic regression analysis identified MV score >28
(p 5 0.008), PAsP >265 mm Hg (p 5 0.023) and cardiac output
<23.151 liters/min (p 5 0.001) as significant predictors of a fatal
outcome. Follow-up of 1 to 16 months (median 8) was available in
20 of 26 survivors in group I, of whom 15 were asymptomatic. The
gain in MV area and the decrease in transmitral gradient and
PAsP obtained immediately after BMV persisted during the
follow-up period.
Conclusions. Emergent BMV is feasible in critically ill patients.
In-hospital survivors have excellent clinical and hemodynamic
status at intermediate follow-up.
(J Am Coll Cardiol 1998;32:154–8)
©1998 by the American College of Cardiology
Rheumatic heart disease (RHD) is a major cardiac problem in
India. Patients often remain untreated until a very advanced
stage because of poverty, ignorance and an inadequate primary
health care infrastructure. In India 6 million children are
affected by RHD, and 25% of them have mitral stenosis (MS)
(1). Many of these patients present in a critically ill condition.
Unlike patients with end-stage myocardial dysfunction in val-
vular regurgitant lesions, patients with MS and significant
cardiovascular compromise can lead a productive life, if the
stenosis is relieved.
Since its introduction by Inoue et al. (2) and Lock et al. (3),
balloon mitral valvotomy (BMV) has evolved into an effective
therapeutic modality for patients with MS, providing satisfac-
tory short- and intermediate-term results. Many clinical trials
(4–8) have established the safety and efficacy of this technique
when offered as an elective procedure. Turi et al. (9) found
comparable hemodynamic improvement after elective BMV
and surgical commissurotomy. Thus, BMV has emerged as an
attractive alternative to surgical treatment for selected pa-
tients. However, the results of elective BMV cannot be extrap-
olated to severely ill patients who undergo emergent relief of
MS and is especially true for emergent operations because
general anesthesia, thoracotomy and cardiopulmonary bypass
have much higher risks in these patients, who often present
with multiorgan failure. Although some earlier studies of BMV
(10,11) included a few such critically ill patients, they remain
poorly characterized as a group. The present study therefore
sought to evaluate the feasibility, efficacy and safety of emer-
gent BMV in patients with cardiac arrest, cardiogenic shock or
refractory pulmonary edema to provide better definition of
factors associated with both favorable and unfavorable out-
comes in these patients.
Methods
This was a retrospective study carried out at a tertiary
referral center in Mumbai, India.
Patients. Data from 558 patients with MS undergoing
percutaneous BMV from January 1, 1993 to December 31,
1994 were reviewed. Of these 558 patients, 40 underwent BMV
as an emergent procedure (group I) and 518 as an elective
procedure (group II). The inclusion criteria for group I were
severe MS (mitral valve [MV] area ,1.0 cm2) and any of the
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following: 1) Cardiogenic shock, defined as systolic blood
pressure ,80 mm Hg with evidence of tissue hypoperfusion in
the form of weak peripheral pulses; cold extremities; oliguria
(urinary output ,0.5 ml/kg per hr); or altered sensorium,
which persisted despite vigorous medical treatment, including
inotropic support. 2) Refractory pulmonary edema, defined as
persistent pulmonary edema and inability to maintain ade-
quate oxygenation (PaO2 $60 mm Hg) without ventilatory
support despite adequate diuretic therapy and optimal treat-
ment to control precipitating causes, such as chest infection,
anemia and rapid ventricular rates in atrial fibrillation. 3)
Postcardiac arrest state, which included patients who underwent
successful cardiopulmonary resuscitation (CPR) after in-
hospital cardiac arrest.
All group I patients underwent a baseline clinical evalua-
tion for severity of MS, estimation of pulmonary hypertension
and factors related to the recent deterioration. They were
initially managed in the intensive coronary care unit, and all
attempts were made to stabilize their condition by means of
optimal ventilatory and inotropic support. Efforts were also
made to identify and treat the precipitating factors, such as
anemia, infection, arrhythmias and drug (digoxin) toxicity. All
patients underwent elective intubation, and positive pressure
ventilation was initiated. Group I patients underwent BMV to
provide relief of MS as a life-saving measure. The only
exclusion criteria were (transthoracic) echocardiographic evi-
dence of left atrial thrombus and mitral regurgitation (MR)
grade .1. Severe subvalvular disease and calcification were not
considered contraindications for the procedure.
Echocardiography. Two-dimensional echocardiography
was performed along with spectral and color Doppler evalua-
tion before and after the procedure. The MV apparatus of
each patient was assessed according to the Wilkins et al. (12)
scoring system. Higher scores represented more deformed
valves. Doppler echocardiography along with color flow map-
ping was used for assessing MV area, MV gradients and
pulmonary artery pressure (PAsP) and for quantifying MR
severity before and after the procedure. MR was graded as 0 to
3 according to regurgitant jet area/left atrial area ratio: grade
0 5 absence of MR; grade 1 5 MR ,20%; grade 2 5 MR 20%
to 40%; grade 3 5 MR .40%. Echocardiographic variables
analyzed for differences between the two groups included MV
area by planimetry and pressure half-time, MV gradients, left
atrial size, left ventricular end-systolic volume, left ventricular
end-diastolic volume, MR grade and PAsP.
Cardiac catheterization. Patients whose general condition
had necessitated artificial ventilation received general anesthe-
sia with vecuronium (0.08 to 0.1 mg/kg body weight) with
nitrous oxide supplementation. Left femoral artery and venous
sheaths were introduced. Pigtail and NIH catheters were used
for left and right heart catheterization, respectively. Oxymetric
and pressure data were obtained before the procedure. Car-
diac output was calculated using the Fick principle. Transsep-
tal puncture was performed through the right femoral vein by
previously described techniques (13,14). Injection of contrast
medium through the Brockenborough needle was used to
identify the interatrial septum and to confirm entry into the left
atrium. After transseptal puncture, 100 U/kg of heparin was
administered. The transmitral gradient (TMG) was then mea-
sured, and BMV was performed using the Inoue balloon
technique (2). A conservative approach to balloon sizing was
used to minimize the chance of producing MR in group I
patients. The first inflation was usually adjusted to 4 mm below
the optimal diameter ([height/10] 1 10 cm), with subsequent
stepwise increments of 1 mm (15). The end point of dilation in
group I was at least a 50% reduction in the mean transmitral
gradient or a final mean gradient of ,8 mm Hg (whichever was
lesser) or the occurrence of acute MR. In group II patients,
every effort was made to minimize the pressure gradients
without oversizing the balloon, which could cause MR. Imme-
diately after BMV, all hemodynamic measurements were
repeated without altering the ventilatory settings. These in-
cluded determination of the transvalvular pressure gradient,
estimation of systemic and PAsP and oxymetry. MR was
assessed clinically and hemodynamically and by color Doppler.
Follow-up. Twenty of 26 survivors were followed up and
assessed for New York Heart Association functional class,
estimation of effort tolerance by a treadmill exercise test,
occurrence of restenosis and MR. Serial echocardiograms were
obtained for evaluation of MV area, TMGs, PAsP and MR
severity.
Definition of success. Emergent BMV (group I) was
deemed successful if there was an improvement in clinical
status, with a significant reduction in TMG (as outlined earlier
for the end point of dilation); less than grade 2 MR, with
resolution of pulmonary edema; and improvement in tissue
perfusion. Elective BMV (group II) was considered successful
if the final MV area was .1.5 cm2 or the gain in MV area was
.50% than the predilation MV area, with MR less than grade
2. BMV in group I was performed as a life-saving measure by
providing enough relief of the stenosis without running the risk
of producing MR (by undersizing the balloon). In group II the
goal was to provide an optimal hemodynamic result. Different
criteria were thus used for judging success in the two groups,
the criteria being less stringent in group I.
Statistical analysis. Continuous variables are reported as
mean value 6 SD. A p value ,0.05 was considered significant.
Comparisons of hemodynamic variables within a group and
between the two groups (emergent [group I] and elective
Abbreviations and Acronyms
BMV 5 balloon mitral valvotomy
CPR 5 cardiopulmonary resuscitation
MR 5 mitral regurgitation
MS 5 mitral stenosis
MV 5 mitral valve
PAsP 5 pulmonary artery systolic pressure
RHD 5 rheumatic heart disease
TMG 5 transmitral gradient
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percutaneous transvenous mitral commissurotomy [group II])
were made using the student t test.
Baseline characteristics contributing to fatal outcome were
identified by multivariate analysis. Univariate (chi-square and
t test) analysis was used to determine the differences in the two
groups, and multiple logistic regression was subsequently
performed using the variables to determine which of them
independently correlated with outcome.
Results
Baseline characteristics. Patients who underwent emer-
gent BMV were older than those who underwent elective
BMV (40 6 13 vs. 31 6 9 years, p , 0.05). Of the 40 group I
patients, 26 (65%) were in cardiogenic shock, 11 (27.5%) had
refractory pulmonary edema, and 3 (7.5%) had undergone
successful CPR for cardiac arrest. Four patients in the cardio-
genic shock group also had pulmonary edema, and all three
patients in the cardiac arrest group were in cardiogenic shock
after resuscitation. When the two groups were compared, atrial
fibrillation was more frequent (30% vs. 9%, p , 0.05), MV
score was higher (7.4 6 1.2 vs. 6.4 6 1, p , 0.001), MV area was
lower (0.74 6 0.17 vs. 0.86 6 0.14, p , 0.001), and PAsP was
higher (64 6 14 vs. 51 6 12 mm Hg, p , 0.001) in group I.
Post-BMV outcome. Twenty-four (60%) of 40 patients in
group I had an uneventful recovery after the procedure. Of the
remaining 16 patients, 14 (35%) died, including 4 who devel-
oped grade 3 MR. An additional two patients who developed
grade 3 MR survived after emergent MV replacement. These
adverse outcomes were more commonly seen in patients with
high MV scores, and occurred in 5 of 24 patients with an MV
score ,8 and in 11 of 16 with an MV score $8 (p , 0.01). In
group I, 7 of 14 deaths were related to BMV because of severe
MR or failed BMV, or both and 7 were unrelated to BMV (4
from septicemic shock, 3 from multiple organ failure). Hemo-
dynamic variables before and after BMV and at follow-up in
group I survivors are presented in Table 1.
Age, gender, presence of pneumonia, pulmonary edema,
congestive cardiac failure, atrial fibrillation, systemic systolic
blood pressure ,80 mm Hg, acute renal failure, PO2
,60 mm Hg, time from admission to BMV, hemoglobin level,
MV score, PAsP and cardiac output were assessed by univar-
iate analysis. Continuous variables were converted into two
discriminant groups by appropriately selecting the cutoff points
to assess their contribution to mortality. Of these variables,
systemic systolic blood pressure ,80 mm Hg (p 5 0.04), PO2
,60 mm Hg (p 5 0.04), MV score $8 (p 5 0.031), cardiac
output ,3.15 liters/min (p 5 0.0047) and PAsP .65 mm Hg
(p 5 0.025) were found to be significant. Baseline variables
were also analyzed in a multivariate model to account for the
interactions between various confounding variables. Using a
stepwise logistic regression model, MV score $8 (p 5 0.008),
PAsP $65 mm Hg (p 5 0.023) and cardiac output #3.15
liters/min (p 5 0.001) were found to be significant predictors of
fatal outcome.
Postmortem analysis. Postmortem examination of the
heart was performed in all patients who died after emergent
BMV. Table 2 displays the MV morphologic findings. Nine
patients had commissural splitting of the MV; both medial and
lateral commissures were split in five patients; and only one
commissure was split in the remaining four patients. Seven of
the nine patients with adequate commissural splitting died
secondary to multiorgan failure or septicemic shock and were
considered to have died of causes “unrelated to the proce-
dure.” The other two patients with commissural splitting also
developed significant MR. In five patients neither commissure
had been split, including two with MR. All four patients had
MR (leaflet tear in three, chordal rupture in one). The seven
patients who died after failed BMV or MR or both were
considered to have died of causes “related to the procedure.”
Follow-up of patients with emergent BMV. There were 26
survivors in group I, of whom 2 underwent MV replacement
for acute MR. Thus, emergent BMV was successful in 24 of 40
patients. Follow-up data were available in 20 of 24 patients
(mean follow-up 8.2 months, range 1 to 16). Clinical assess-
ment revealed that 15 patients were in functional class I, 4 were
in class II, and 1 was in class III. A treadmill test performed
with the Bruce protocol in these 20 patients revealed a mean
exercise duration of 8.4 6 1.8 min. Table 1 shows that the MV
area, PAsP and peak MV gradient at follow-up were similar to
those observed immediately after BMV, indicating a sustained
clinical and hemodynamic improvement after BMV. No pa-
tient had mitral restenosis.
Discussion
The present study evaluated the feasibility and safety of
BMV in critically ill patients who present with cardiogenic
shock and resistant pulmonary edema and in those successfully
resuscitated after cardiopulmonary arrest. An attempt was
made to identify baseline variables that could have contributed
to an unfavorable outcome, even after a technically successful
procedure.
Because of socioeconomic constraints, many patients in
India do not undergo elective relief of MS and present to the
hospital in an advanced stage, with pulmonary edema, low
cardiac output or cardiogenic shock. Often these patients have
Table 1. Hemodynamic Variables Before and After Balloon Mitral
Valvotomy and at Follow-Up in Group I Patients
Before BMV After BMV At Follow-Up
MV area (cm2) 0.74 6 0.17 1.51 6 0.38 1.4 6 0.26
PAsP (mm Hg) 64 6 14 50 6 11 54 6 13
LAP (mm Hg) 24 6 8 13 6 7
Peak TMG (mm Hg) 29 6 6 16 6 8
Mean TMG (mm Hg) 21 6 8 6 6 4
LVEDP (mm Hg) 3.5 6 2.9 7.1 6 3.8
CO (liters/min) 2.0 6 0.6 3.2 6 0.7
Data presented are mean value 6 SD. BMV 5 balloon mitral valvotomy;
CO 5 cardiac output; LAP 5 left atrial mean pressure; LVEDP 5 left
ventricular end-diastolic pressure; MV 5 mitral valve; PAsP 5 pulmonary artery
systolic pressure; TMG 5 transmitral gradient.
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a precipitating event, such as respiratory infection, anemia and
atrial fibrillation, that leads to sudden deterioration. Surgical
commissurotomy for emergency relief has high mortality be-
cause of these associated factors. According to Barlow (16),
the operative mortality rate for emergency closed surgical
valvotomy is up to 25%. In our study, the mortality rate was
40%. However, this needs to be considered in the context of
the poor general condition of our patients (i.e., multiple organ
failure, significantly deformed valves and nonavailability of
surgical interventions for logistic reasons). Despite a high
mortality rate, emergent BMV is an acceptable alternative for
these patients, almost all of whom will die without mechanical
relief. Moreover, unlike surgical relief, BMV can be performed
without thoracotomy and significant blood loss.
Emergent BMV results. Emergent BMV was successful in
24 patients. The procedure was regarded as unsuccessful in the
14 patients who died after BMV and in 2 who developed severe
MR but survived after MVR. Of the 14 patients who died,
BMV was technically “successful” in 7 in relieving the MS
without producing acute MR. Despite adequate relief of MS,
these patients succumbed either to septicemic shock or multi-
organ failure. In the remaining seven patients, BMV was
unsuccessful because of failure to split the commissures or
development of significant MR. Two other previous studies
(10,11) have reported the results of emergency BMV. Mu et al.
(10) studied 10 patients; patient age, incidence of atrial
fibrillation, MV scores, and MV gradients were comparable to
those of our patients. The higher success rate of 70% in their
series is probably due to the better general condition of their
patients at presentation, which is also suggested by the fact that
seven of our patients died despite adequate relief of the
stenosis. Patel et al. (11) similarly reported good results in 12
young patients with intractable heart failure undergoing BMV.
In their series, the patients were younger, with relatively better
MV morphology and a shorter duration of the disease.
Ideally, group I patients should have undergone transesoph-
ageal echocardiography before BMV to identify left atrial or
appendage thrombus because they were at higher risk for
thromboembolism in view of the high incidence of atrial
fibrillation, low cardiac output and advanced age. However, it
is remarkable that none of our patients had any thromboem-
bolic complications. Transesophageal echocardiography was
not performed in our patients because this modality was not
available to us during the study period, and it was not feasible
to transfer the patients elsewhere.
Problems of emergent BMV. In the present study emergent
BMV was undertaken in critically ill patients and required a
well trained team to rapidly and efficiently perform the proce-
dure. All 40 cases were attempted only after the total number
of cases done at our center was .500, with a mortality rate of
elective procedures ,1%. Our patients had low cardiac output,
were receiving inotropic support and had tachycardia; hence,
hemodynamic assessment of MV gradients and pulmonary
artery pressures was often difficult. In such patients the end
point of the procedure was defined on the basis of cardiac
index rather than TMG. In some patients with a high PAsP and
associated tricuspid valve regurgitation and large right atria,
the transseptal puncture was also technically demanding. The
Inoue balloon technique was preferred over the double-
balloon technique because the former is simpler, can be
performed by a single operator and is quicker (17). Post-BMV
management of the patients was difficult in view of cardiac
cachexia, severe pulmonary hypertension, respiratory infec-
tions, impaired renal and cerebral function and stiff lungs,
which persisted for some time, even after the mechanical relief.















1 54/F Both Sev Sev Mild AML tear MR
2 37/M One Sev Mod None — MOF
3 51/M Neither Sev Sev None — Failed BMV*
4 24/M One Sev Sev Mod PML tear MR
5 35/F Both Mod Mod None — Septicemic shock
6 42/M Both Mod Mild None LA
thrombus
MOF
7 38/F Both Mod Mild None — Septicemic shock
8 44/F One Mod Mod None — Septicemic shock
9 29/M One Sev Mild None — MOF
10 25/F Neither Sev Sev Mod PML tear MR, failed BMV
11 40/M Both Sev Mod None — Septicemic shock
12 51/F Neither Sev Sev Mild Chordal
rupture
MR, failed BMV
13 48/F Neither Mod Mod None — Failed BMV*
14 46/F Neither Mod Mod None — Failed BMV*
* Eventually resulted in unrelieved cardiogenic shock and death. AML 5 anterior mitral leaflet; BMV 5 balloon
mitral valvotomy; F 5 female; LA 5 left atrial; M 5 male; Mod 5 moderate; MOF 5 multiple organ failure; MR 5
mitral regurgitation; PML 5 posterior mitral leaflet; Pt 5 patient; Sev 5 severe.
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The problems were magnified in those with failed BMV and
severe MR.
Follow-up. Most of the patients who were discharged from
the hospital after the emergent BMV remained free from
symptoms or were mildly symptomatic, which was gratifying in
view of their poor state at presentation. The increase in MV
area and the decrease in PAsP and TMG persisted at follow-
up. Restenosis was not seen at intermediate follow-up.
Pathologic features of BMV: implications for mechanisms
and complications. The basic pathoanatomic features of the
MV rendered stenotic by virtue of RHD provide a rational
basis for the success of both operative and balloon catheter
intervention: The fundamental pathologic feature limiting
leaflet mobility is fusion of one or both commissures (18).
Thus, despite the fact that the leaflets are typically thickened
and may at times contain calcific deposits, the orifice area can
be significantly augmented by splitting the fused commissures.
In the present study the success of BMV was related to
satisfactory splitting of fused commissures. Failure to achieve
success was related to inability to traverse or dilate a severely
diseased MV because of severe commissural fusion and sub-
valvular disease. Among the group I 14 patients who died, only
1 was assessed as having grade 4 subvalvular affection at
echocardiography. However, at autopsy, five of these patients
had severe subvalvular affection in the form of complete fusion
of the chordae and papillary muscles. Therefore, transthoracic
echocardiographic estimation of subvalvular deformity in fact
underestimated the degree of subvalvular disease. Whether
such an underestimation also occurred in group II is not
known, as the mortality rate in group II was too low to draw
any meaningful conclusions. The other major complication of
the present study was MR. The mechanism of severe MR after
BMV was multifactorial. MR was precipitated by either a tear
of a commissure or a leaflet, rupture of the chordae or
incomplete closure after splitting of the commissures because
of rigid valve leaflets or shortened chordae, or both.
Limitations of the study. This was not a randomized study
comparing BMV with surgical intervention. However, prospec-
tive randomization would be difficult because many candidates
with highly deformed valves on echocardiography are not
considered eligible for closed operation, at least at our hospi-
tal. Therefore, superiority of BMV over surgical intervention
could not be established. Four of the 24 patients with success-
ful emergent BMV were lost to follow-up.
Conclusions. The patients presenting for emergent BMV
were in a critical clinical and hemodynamic state and were
significantly older, with a higher incidence of atrial fibrillation,
a smaller MV area and a higher PAsP and with MV apparatus
that appeared more deformed on two-dimensional echocardi-
ography. High MV score and PAsP and low cardiac output
contribute significantly to in-hospital mortality. Despite high
mortality and morbidity, emergent BMV is arguably the only
viable option for these critically ill patients.
We are grateful to Dilip Karnad, MD for useful suggestions in manuscript
preparation and help with the statistical analysis.
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